SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-23-026158
Filing Date
2023-08-01
Accepted
2023-08-01 07:00:12
Documents
13
Period of Report
2023-07-28
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 51736
  Complete submission text file 0001493152-23-026158.txt   271240

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE cing-20230728.xsd EX-101.SCH 3769
3 XBRL DEFINITION FILE cing-20230728_def.xml EX-101.DEF 26627
4 XBRL LABEL FILE cing-20230728_lab.xml EX-101.LAB 36718
5 XBRL PRESENTATION FILE cing-20230728_pre.xml EX-101.PRE 25251
7 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 5222
Mailing Address 1901 W. 47TH PLACE KANSAS CITY KS 66205
Business Address 1901 W. 47TH PLACE KANSAS CITY KS 66205 (913) 942-2300
Cingulate Inc. (Filer) CIK: 0001862150 (see all company filings)

IRS No.: 863825535 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40874 | Film No.: 231129590
SIC: 2834 Pharmaceutical Preparations